Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women

Chang, Yung-Ling
Hsieh, Yao-Yuan
Tsai, Horng-Der

December 2006

SummaryObjectiveTo determine the minimal effective daily dose of gonadotropin-releasing hormone (GnR...

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass

G. Lupoli
C. Di Carlo
V. Nuzzo
G. Vitale
D. Russo
S. Palomba
C. Nappi

September 1997

Women with amenorrhea and polycystic ovaries (PCO) seem to present a relative degree of protection a...

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS

Yasuho Yanagihara
Atsushi Tanaka
Motoi Nagayoshi
Izumi Tanaka
Rina Shinohara
Fumihisa Fukushima
Akihiro Tanaka
Motoharu Ohno
Takashi Yamaguchi
Atsuo Itakura

January 2022

Abstract Purpose To analyze the therapeutic efficacy of a modified controlled ovarian stimulation (C...

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase

Sagnella, Francesca
Apa, Rosanna (ORCID:0000-0003-0143-9114)
Guido, Maurizio (ORCID:0000-0001-6554-0874)
Villa, Paola (ORCID:0000-0002-4402-6988)
Spadoni, Valentina
Miceli, Fiorella (ORCID:0000-0002-9485-5784)
Lanzone, Antonio (ORCID:0000-0003-4119-414X)

January 2009

To evaluate the effects of the GnRH antagonist cetrorelix on the gonadal axis in patients with polyc...

Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders

Fauser, B.C.
Laven, J.S.
de Jong, D.
Macklon, N.S.

February 2000

The hypothalamic gonadotrophin-releasing hormone (GnRH) stimulates synthesis and secretion of lutein...

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

Kaltsas, T.
Pontikides, N.
Krassas, G. E.
Seferiadis, K.
Lolis, D.
Messinis, I. E.

January 1998

The suppression of the pituitary-gonadal axis by the administration of gonadotrophin-releasing hormo...

Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome

Runa Ozelci
Serdar Dilbaz
Berna Dilbaz
Derya Akdag Cırık
Saynur Yılmaz
Ozlem Moraloglu Tekin

March 2019

Objective: To evaluate the effect of the GnRH antagonist on gonadotropin ovulation induction in wome...

Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism

De Leo, V.
Fulghesu, A. M.
La Marca, A.
Morgante, G.
Pasqui, L.
Talluri, B.
Torricelli, M.
Caruso, A.

January 2000

The objective of this prospective randomized study was to evaluate and compare the hormonal and clin...

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome.

GENAZZANI, Alessandro
F., Petraglia
C., Battaglia
O., Gamba
VOLPE, Annibale
A. R., Genazzani

January 1997

To evaluate the hormonal and clinical follow-up after the suspension of a longterm therapy with GnRH...

The use of combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment

GENAZZANI, A. D.
BATTAGLIA, C.
GAMBA, O.
PETRAGLIA, F.
MALAVASI, B.
GENAZZANI, A. R.

January 2000

PURPOSE: The fertility rate in women with polycystic ovary disease (PCOD) is influenced by the type...

The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.

MAIS, VALERIO
Kazer R. R
Cetel N. S
Rivier J
Vale W
Yen S. S.

January 1986

A potent GnRH antagonist, [Ac-delta 3-Pro1,p-F-D-Phe2,D-Trp3,6]GnRH (4F-Antag), was used as a probe ...

EXPERIMENTAL STUDY Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells

J M Weiss
K Oltmanns
E M Gürke
S Polack
F Eick
R Felberbaum
K Diedrich
O Ortmann

March 2015

Objective: GnRH antagonists have recently been introduced for the prevention of premature LH surges ...

Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol‐pretreated women with polycystic ovary syndrome

Su Hee Kim
Jessica A. Lundgren
James T. Patrie
Christine M. Burt Solorzano
Christopher R. McCartney

April 2022

Abstract Women with polycystic ovary syndrome (PCOS) demonstrate gonadotropin‐releasing hormone (GnR...

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrom

GENAZZANI AD
F. PETRAGLIA
BATTAGLIA C
GAMBA O
VOLPE A
GENAZZANI AR

January 1997

OBJECTIVE: To evaluate the hormonal and clinical follow-up after the suspension of a longterm therap...

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles

Ubaldi, Filippo
Albano, Carola
Camus, Marguerite
Smitz, Johan
Van Steirteghem, André
Devroey, Paul
Peukert, Manfred
Riethmüller-Winzen, Hilde

July 1996

In the present study, subtle serum progesterone rise (≤ 1.1 ng/ml) during the late follicular phase ...

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women

Chang, Yung-Ling
Hsieh, Yao-Yuan
Tsai, Horng-Der

December 2006

SummaryObjectiveTo determine the minimal effective daily dose of gonadotropin-releasing hormone (GnR...

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass

G. Lupoli
C. Di Carlo
V. Nuzzo
G. Vitale
D. Russo
S. Palomba
C. Nappi

September 1997

Women with amenorrhea and polycystic ovaries (PCO) seem to present a relative degree of protection a...

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS

Yasuho Yanagihara
Atsushi Tanaka
Motoi Nagayoshi
Izumi Tanaka
Rina Shinohara
Fumihisa Fukushima
Akihiro Tanaka
Motoharu Ohno
Takashi Yamaguchi
Atsuo Itakura

January 2022

Abstract Purpose To analyze the therapeutic efficacy of a modified controlled ovarian stimulation (C...

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase

Sagnella, Francesca
Apa, Rosanna (ORCID:0000-0003-0143-9114)
Guido, Maurizio (ORCID:0000-0001-6554-0874)
Villa, Paola (ORCID:0000-0002-4402-6988)
Spadoni, Valentina
Miceli, Fiorella (ORCID:0000-0002-9485-5784)
Lanzone, Antonio (ORCID:0000-0003-4119-414X)

January 2009

To evaluate the effects of the GnRH antagonist cetrorelix on the gonadal axis in patients with polyc...

Gonadotrophin-releasing hormone antagonists: application in ovary-stimulating and sex-steroid dependent disorders

Fauser, B.C.
Laven, J.S.
de Jong, D.
Macklon, N.S.

February 2000

The hypothalamic gonadotrophin-releasing hormone (GnRH) stimulates synthesis and secretion of lutein...

Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome

Kaltsas, T.
Pontikides, N.
Krassas, G. E.
Seferiadis, K.
Lolis, D.
Messinis, I. E.

January 1998

The suppression of the pituitary-gonadal axis by the administration of gonadotrophin-releasing hormo...

Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome

Runa Ozelci
Serdar Dilbaz
Berna Dilbaz
Derya Akdag Cırık
Saynur Yılmaz
Ozlem Moraloglu Tekin

March 2019

Objective: To evaluate the effect of the GnRH antagonist on gonadotropin ovulation induction in wome...

Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism

De Leo, V.
Fulghesu, A. M.
La Marca, A.
Morgante, G.
Pasqui, L.
Talluri, B.
Torricelli, M.
Caruso, A.

January 2000

The objective of this prospective randomized study was to evaluate and compare the hormonal and clin...

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome.

GENAZZANI, Alessandro
F., Petraglia
C., Battaglia
O., Gamba
VOLPE, Annibale
A. R., Genazzani

January 1997

To evaluate the hormonal and clinical follow-up after the suspension of a longterm therapy with GnRH...

The use of combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment

GENAZZANI, A. D.
BATTAGLIA, C.
GAMBA, O.
PETRAGLIA, F.
MALAVASI, B.
GENAZZANI, A. R.

January 2000

PURPOSE: The fertility rate in women with polycystic ovary disease (PCOD) is influenced by the type...

The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe.

MAIS, VALERIO
Kazer R. R
Cetel N. S
Rivier J
Vale W
Yen S. S.

January 1986

A potent GnRH antagonist, [Ac-delta 3-Pro1,p-F-D-Phe2,D-Trp3,6]GnRH (4F-Antag), was used as a probe ...

EXPERIMENTAL STUDY Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells

J M Weiss
K Oltmanns
E M Gürke
S Polack
F Eick
R Felberbaum
K Diedrich
O Ortmann

March 2015

Objective: GnRH antagonists have recently been introduced for the prevention of premature LH surges ...

Acute progesterone feedback on gonadotropin secretion is not demonstrably altered in estradiol‐pretreated women with polycystic ovary syndrome

Su Hee Kim
Jessica A. Lundgren
James T. Patrie
Christine M. Burt Solorzano
Christopher R. McCartney

April 2022

Abstract Women with polycystic ovary syndrome (PCOS) demonstrate gonadotropin‐releasing hormone (GnR...

A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrom

GENAZZANI AD
F. PETRAGLIA
BATTAGLIA C
GAMBA O
VOLPE A
GENAZZANI AR

January 1997

OBJECTIVE: To evaluate the hormonal and clinical follow-up after the suspension of a longterm therap...

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles

Ubaldi, Filippo
Albano, Carola
Camus, Marguerite
Smitz, Johan
Van Steirteghem, André
Devroey, Paul
Peukert, Manfred
Riethmüller-Winzen, Hilde

July 1996

In the present study, subtle serum progesterone rise (≤ 1.1 ng/ml) during the late follicular phase ...

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women

Chang, Yung-Ling
Hsieh, Yao-Yuan
Tsai, Horng-Der

December 2006

SummaryObjectiveTo determine the minimal effective daily dose of gonadotropin-releasing hormone (GnR...

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass

G. Lupoli
C. Di Carlo
V. Nuzzo
G. Vitale
D. Russo
S. Palomba
C. Nappi

September 1997

Women with amenorrhea and polycystic ovaries (PCO) seem to present a relative degree of protection a...

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS

Yasuho Yanagihara
Atsushi Tanaka
Motoi Nagayoshi
Izumi Tanaka
Rina Shinohara
Fumihisa Fukushima
Akihiro Tanaka
Motoharu Ohno
Takashi Yamaguchi
Atsuo Itakura

January 2022

Abstract Purpose To analyze the therapeutic efficacy of a modified controlled ovarian stimulation (C...

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase

Abstract

Extracted data

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase

Abstract

Extracted data

Related items

Related items